Product
ARV-471 + Everolimus
Aliases
ARV-471 in combination with Everolimus
1 clinical trial
1 indication
Indication
Breast CancerClinical trial
A Phase 1b Trial of ARV-471 in Combination With Everolimus in Patients With ER+, HER2- Advanced or Metastatic Breast CancerStatus: Active (not recruiting), Estimated PCD: 2024-05-30